Endoscopic Retrograde Cholangiopancreatography Market by Product Type (Endoscopes, Endotherapy Devices, Imaging Systems, Energy Devices, And Others), Application (Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, And Pancreatic Duct Stenting), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, And Others): Global Opportunity Analysis and Industry Forecast, 2019-2027
- ALL4621560
- 265 Pages
- April 2021
- Medical Devices
Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure used to diagnose diseases of the gallbladder, biliary system, pancreas, and liver. ERCP devices use a combination of fluoroscopic imaging and luminal endoscopy for the diagnosis and treatment of pancreatobiliary system related disorders. By product type, the endoscopic retrograde cholangiopancreatography market is categorized into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Endotherapy devices are majorly used for the treatment of various medical conditions such as Barrett's disease., biliary disease, colitis, Crohn's disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. The endotherapy devices segment is further categorized into sphincterotome, guidewire, balloon, basket, lithotripters, stent, grasping forceps, cannula, and single use balloon dilator
The growth of the global endoscopic retrograde cholangiopancreatography (ERCP) market is majorly driven by rise in incidences of gastrointestinal and chronic biliary disorders such as Barrett's disease, biliary disease, colitis, Crohn's disease, gastroesophageal reflux disorder (GERD), liver disease, pancreatitis, inflammatory bowel disease, and peptic ulcer disease. Further, rapid increase in frequencies of benign tumors of the liver and pancreas coupled with surge in aging population and rise in awareness related to devices used in ERCP for the treatment of disorders drive the market growth. However, high costs associated with treatment from ERCP and side-effects of the procedure such as post-ERCP pancreatitis are expected to hamper the growth of the market. On the contrary, emerging countries possess high growth potential, owing to improvement of healthcare infrastructures in these countries.
The endoscopic retrograde cholangiopancreatography market is segmented into product type, application, end user, and region. On the basis of product type, into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Further, the endotherapy devices segment is divided into sphincterotome, lithotripter, stents, cannulas, forceps, snares, catheters, guiding wires, balloons, baskets, and others. By application, it is divided into biliary sphincterotomy, biliary dilatation, biliary stenting, pancreatic sphincterotomy, pancreatic duct dilatation, and pancreatic duct stenting. By end user, it is segregated into hospitals & clinics, ambulatory surgery centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the key players operating in the endoscopic retrograde cholangiopancreatography market include Olympus Corporation, Conmed Corporation, Hobbs Medical, Inc., TeleMed Systems, Inc., Boston Scientific Corporation, Cook Group Incorporation, Ambu, Inc., Becton, Dickinson and Company, Fujifilm Holding Corporation, and Medtronic Plc.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current global endoscopic retrograde cholangiopancreatography market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment.
The endoscopic retrograde cholangiopancreatography market forecast is studied from 2019 to 2027.
The market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative products facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product Type
• Endoscopes
• Endotherapy Devices
o Sphincterotome
o Lithotripter
o Stents
o Cannulas
o Forceps
o Snares
o Catheters
o Guiding Wires
o Balloons
o Baskets
o Others
• Imaging Devices
• Energy Devices
• Others
By Application
• Biliary Sphincterotomy
• Biliary Dilatation
• Biliary Stenting
• Pancreatic Sphincterotomy
• Pancreatic Duct Dilatation
• Pancreatic Duct Stenting
By End User
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA
KEY MARKET PLAYERS
• Olympus Corporation,
• Conmed Corporation,
• Hobbs Medical, Inc.
• TeleMed Systems, Inc.
• Boston Scientific Corporation
• Cook Group incorporation
• Fujifilm holdings Corporation
• Becton, Dickinson and Company
• Medtronic, Plc.
• Ambu Inc.
List of other players in the value chain (profiles not included in the report):
• Jiangsu ATE Medical Technology Co, Ltd.
• Johnson & Johnson Services
• Changzhou Health Microport Medical Device Co, Ltd.
• Merit Medical System, Inc.
• Karl Storz
1.1.Report description
1.1.1.Key benefits for stakeholders
1.1.2.Key market segments
1.2.Research methodology
1.2.1.Secondary research
1.2.2.Primary research
1.2.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Top player positioning, 2019
3.4.Porter’s five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in incidences of gastrointestinal and chronic biliary disorders
3.5.1.2.Increase in frequencies of benign tumors of the liver and pancreas
3.5.1.3.Increase in ageing population
3.5.2.Restraints
3.5.2.1.High costs associated with treatment from ERCP devices
3.5.2.2.Side-effects of the procedure such as post-ERCP pancreatitis
3.5.3.Opportunity
3.5.3.1.Rise in awareness
3.6.Impact analysis of COVID-19 on market
CHAPTER 4:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Endoscopes
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Endotherapy Devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Sphincterotome
4.3.2.1.1.Market size and forecast
4.3.2.2.Lithotripter
4.3.2.2.1.Market size and forecast
4.3.2.3.Stents
4.3.2.3.1.Market size and forecast
4.3.2.4.Cannula
4.3.2.4.1.Market size and forecast
4.3.2.5.Forceps
4.3.2.5.1.Market size and forecast
4.3.2.6.Snare
4.3.2.6.1.Market size and forecast
4.3.2.7.Catheter
4.3.2.7.1.Market size and forecast
4.3.2.8.Guiding wires
4.3.2.8.1.Market size and forecast
4.3.2.9.Balloons
4.3.2.9.1.Market size and forecast
4.3.2.10.Basket
4.3.2.10.1.Market size and forecast
4.3.2.11.Others
4.3.2.11.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Imaging Devices
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Energy Devices
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Others
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Biliary Sphincterotomy
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Biliary Dilatation
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Biliary Stenting
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Pancreatic Sphincterotomy
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Pancreatic Duct Dilatation
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
5.7.Pancreatic Duct Stenting
5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country
CHAPTER 6:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & Clinics
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Ambulatory surgery centers
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Others
6.4.1.Market size and forecast
6.4.2.Market analysis, by country
CHAPTER 7:ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America endoscopy device market, by country
7.2.2.1.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.2.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.3.U.S. Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.2.4.Canada Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.5.Canada Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.6.Canada Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.2.7.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.2.8.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.2.9.Mexico Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.2.3.North America Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.2.4.North America Endoscopic Retrograde Cholangiopancreatography Market, by application
7.2.5.North America Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Endoscopic Retrograde Cholangiopancreatography Market, by country
7.3.2.1.Germany Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.2.Germany Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.3.Germany Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.4.France Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.5.France Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.6.France Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.7.UK Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.8.UK Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.9.UK Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.10.Italy Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.12.Italy Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.13.Italy Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.14.Spain Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.15.Spain Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.16.Spain Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.2.17.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.2.18.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.2.19.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.3.3.Europe Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.3.4.Europe Endoscopic Retrograde Cholangiopancreatography Market, by application
7.3.5.Europe Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by country
7.4.2.1.Japan Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.2.Japan Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.3.Japan Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.4.China Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.5.China Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.6.China Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.7.Australia Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.8.Australia Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.9.Australia Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.10.India Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.11.India Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.12.India Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.13.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.14.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.15.South Korea Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.2.16.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.2.17.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.2.18.Rest of Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.4.3.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.4.4.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by application
7.4.5.Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by country
7.5.2.1.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.2.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.3.Brazil Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.4.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.5.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.6.Saudi Arabia Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.7.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.8.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.9.South Africa Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.2.10.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.2.11.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.2.12.Rest of LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by end user
7.5.3.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by product type
7.5.4.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by application
7.5.5.LAMEA Endoscopic Retrograde Cholangiopancreatography Market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.AMBU INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.BECTON, DICKINSON AND COMPANY
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.3.BOSTON SCIENTIFIC CORPORATION.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.CONMED CORPORATION.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.COOK GROUP INCORPORATION
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.HOBBS MEDICAL, INC.
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.FUJIFILM HOLDINGS CORPORATION.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.MEDTRONIC PLC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.OLYMPUS CORPORATION
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.TELEMED SYSTEM, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
TABLE 01.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE 2019–2027 ($MILLION)
TABLE 02.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOSCOPES, BY REGION, 2019-2027 ($MILLION)
TABLE 03.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY TYPE, 2019-2027 ($MILLION)
TABLE 04.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENDOTHERAPY DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 05.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR IMAGING DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 06.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR ENERGY DEVICES, BY REGION, 2019-2027 ($MILLION)
TABLE 07.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
TABLE 08.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY SPHINCTEROTOMY, BY REGION, 2019-2027 ($MILLION)
TABLE 10.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY DILATATION, BY REGION, 2019-2027 ($MILLION)
TABLE 11.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR BILIARY STENTING BY REGION, 2019-2027 ($MILLION)
TABLE 12.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC SPHINCTEROTOMY BY REGION, 2019-2027 ($MILLION)
TABLE 13.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT DILATATION, BY REGION, 2019-2027 ($MILLION)
TABLE 14.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR PANCREATIC DUCT STENTING, BY REGION, 2019-2027 ($MILLION)
TABLE 15.GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 16.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2027 ($MILLION)
TABLE 17.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.NORTH AMERICA ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 22.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 23.U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 24.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 25.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 26.CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 27.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 28.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 29.MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 30.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 33.EUROPE ENDOSCOPY DEVICEMARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 34.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 35.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 36.GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 37.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 38.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 39.FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 40.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 41.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 42.UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 43.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 44.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 45.ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 46.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 47.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 48.SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 49.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 50.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 51.REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 52.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 53.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 54.EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 55.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 56.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 57.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 58.JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 59.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 60.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 61.CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 62.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 63.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 64.AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 65.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 66.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 67.INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 68.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 69.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 70.SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 73.REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 74.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 75.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 76.ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 77.LAMEA ENDOSCOPY DEVICEMARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 78.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 79.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 80.BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 81.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 82.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 83.SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 84.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 85.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 86.SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 87.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 88.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 89.REST OF LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 90.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
TABLE 91.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 92.LAMEA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 93.AMBU: COMPANY SNAPSHOT
TABLE 94.AMBU: OPERATING SEGMENTS
TABLE 95.AMBU: PRODUCT PORTFOLIO
TABLE 96.BD: COMPANY SNAPSHOT
TABLE 97.BD: OPERATING SEGMENTS
TABLE 98.BD: PRODUCT PORTFOLIO
TABLE 99.BOSTON: COMPANY SNAPSHOT
TABLE 100.BOSTON: OPERATING SEGMENTS
TABLE 101.BOSTON: PRODUCT PORTFOLIO
TABLE 102.CONMED COMPANY SNAPSHOT
TABLE 103.CONMED: OPERATING SEGMENTS
TABLE 104.CONMED: PRODUCT PORTFOLIO
TABLE 105.COOK: COMPANY SNAPSHOT
TABLE 106.COOK: OPERATING SEGMENTS
TABLE 107.COOK: PRODUCT PORTFOLIO
TABLE 108.HOBBS MEDICAL: COMPANY SNAPSHOT
TABLE 109.HOBBS MEDICAL: OPERATING SEGMENTS
TABLE 110.HOBBS MEDICAL: PRODUCT PORTFOLIO
TABLE 111.FUJIFILM: COMPANY SNAPSHOT
TABLE 112.FUJIFILM: OPERATING SEGMENTS
TABLE 113.FUJIFILM: PRODUCT PORTFOLIO
TABLE 114.MEDTRONIC: COMPANY SNAPSHOT
TABLE 115.MEDTRONIC: OPERATING SEGMENTS
TABLE 116.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 117.OLYMPUS: COMPANY SNAPSHOT
TABLE 118.OLYMPUS: OPERATING SEGMENTS
TABLE 119.OLYMPUS: PRODUCT PORTFOLIO
TABLE 120.TELMED: COMPANY SNAPSHOT
TABLE 121.TELEMED: OPERATING SEGMENTS
TABLE 122.TELEMED: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
